Collaboration is key to enriching our commercial and development initiatives. The Eyevance team has a history of successfully licensing therapies and creating strategic alliances in the ophthalmic field, which enables us to consistently offer our partners the best path to positive outcomes.

Eyevance is also dedicated to supporting development stage companies with differentiated innovation by co-investing with other stakeholders.

Use the form below to contact co-founder and Chief Operating Officer Jason Werner to discuss a partnership with Eyevance.

  • This field is for validation purposes and should be left unchanged.